is the tirzepatide shortage over FDA Says Compounded Must Exit Market The GLP-1 drug shortage is

The new lower Medicare prices for the first 10 drugs won't go into effect until January 2026, but the discounts range from 79% for diabetes drug Januvia to 38% for blood cancer drug Imbruvica

During the antenatal visits or other visits at the hospital, the study gynaecologists will verify the compliance

TL;DR Zepbound (tirzepatide) is an FDA-approved injectable medication that works by activating two hormone receptors-GLP-1 and GIP-simultaneously, making it the first dual-agonist weight loss drug

The FDAs new guidance clarifies that, unless theres a legitimate shortage, copying an FDA-approved drug is not permissible

& Pryor, J

The peak is middle age More than 1 in 5 adults aged 50 to 64 (22%) currently take a GLP-1, against just 4% of adults under 30